Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results

Company Overview - Accelerate Diagnostics, Inc. is focused on in vitro diagnostics, addressing global challenges related to antibiotic resistance and sepsis [2] - The company offers the Accelerate Pheno® system and Accelerate PhenoTest® BC kit, which aim to reduce the time required for clinicians to determine optimal antibiotic therapy for severe infections [2] Product Details - The FDA-cleared Accelerate Pheno® system and kit automate sample preparation, providing phenotypic antibiotic susceptibility results in approximately 7 hours from positive blood cultures [2] - External studies suggest that this solution delivers results 1-2 days faster than traditional methods, allowing for earlier optimization of antibiotic selection and dosage tailored to individual patients [2]